Alivus Life Sciences Limited (NSE:ALIVUS)
1,004.50
-40.45 (-3.87%)
Apr 28, 2026, 3:29 PM IST
-3.07% (1Y)
| Market Cap | 123.68B |
| Revenue (ttm) | 25.12B |
| Net Income (ttm) | 5.44B |
| Shares Out | 122.74M |
| EPS (ttm) | 44.23 |
| PE Ratio | 22.78 |
| Forward PE | 20.38 |
| Dividend | 5.00 (0.48%) |
| Ex-Dividend Date | Sep 1, 2025 |
| Volume | 198,165 |
| Average Volume | 106,961 |
| Open | 1,044.95 |
| Previous Close | 1,044.95 |
| Day's Range | 1,001.35 - 1,059.80 |
| 52-Week Range | 819.00 - 1,225.10 |
| Beta | 0.01 |
| RSI | 46.50 |
| Earnings Date | Apr 30, 2026 |